MDT

99.7

-0.07%↓

145.92

+0.05%↑

VEEV

238.84

+1.15%↑

HQY

97.7

+3.12%↑

PHR.US

17.49

+1.22%↑

MDT

99.7

-0.07%↓

145.92

+0.05%↑

VEEV

238.84

+1.15%↑

HQY

97.7

+3.12%↑

PHR.US

17.49

+1.22%↑

MDT

99.7

-0.07%↓

145.92

+0.05%↑

VEEV

238.84

+1.15%↑

HQY

97.7

+3.12%↑

PHR.US

17.49

+1.22%↑

MDT

99.7

-0.07%↓

145.92

+0.05%↑

VEEV

238.84

+1.15%↑

HQY

97.7

+3.12%↑

PHR.US

17.49

+1.22%↑

MDT

99.7

-0.07%↓

145.92

+0.05%↑

VEEV

238.84

+1.15%↑

HQY

97.7

+3.12%↑

PHR.US

17.49

+1.22%↑

Home・Aandelen Lijst・Pulse Biosciences Inc

Pulse Biosciences Inc

Open

SectorGezondheidszorg

15.26 3.11

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

14.57

Max

15.26

Belangrijke statistieken
By Trading Economics
Inkomsten	-217K -19M
Verkoop	86K 86K
EPS	-0.29
Winstmarge	-22,540.698
Werknemers	75
EBITDA	-228K -19M

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+49.97% upside

Dividenden
By Dow Jones
Volgende Winsten	26 mrt 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-179M 958M
Vorige openingsprijs	12.15
Vorige sluitingsprijs	15.26

Nieuwssentiment

By Acuity

50%

164 / 373 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Very Strong Bearish Evidence

16.59 / 17.17 Steun & Weerstand

Pulse Biosciences Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

6 jan 2026, 21:14 UTC

Belangrijke Marktbewegers

Ventyx Biosciences Gains on Report of Possible $1 Billion Eli Lilly Deal

6 jan 2026, 19:23 UTC

Acquisities, Fusies, Overnames

OneStream to Go Private Through $6.4 Billion Hg Acquisition

6 jan 2026, 17:41 UTC

Belangrijke Marktbewegers

Blink Charging Shares Rise as EV Chargers Begin Accepting Cryptocurrency

6 jan 2026, 15:46 UTC

Acquisities, Fusies, Overnames

Advent International Leads InPost Takeover Offer, Sky News Says

6 jan 2026, 15:37 UTC

Belangrijke Marktbewegers

Terrestrial Energy Shares Rise After DOE Agreement For Nuclear Plant Development

6 jan 2026, 23:46 UTC

Marktinformatie

Nikkei May Decline After Hitting Record High -- Market Talk

6 jan 2026, 23:35 UTC

Marktinformatie

Gold Edges Higher Amid Ongoing Geopolitical Tensions -- Market Talk

6 jan 2026, 23:19 UTC

Marktinformatie

Greatland 2Q Gold Output Strong, Sales Soft -- Market Talk

6 jan 2026, 22:53 UTC

Marktinformatie

WiseTech, REA and CAR Look Best Insulated From AI Threat -- Market Talk

6 jan 2026, 22:03 UTC

Acquisities, Fusies, Overnames

Staar Surgical: Merger Proposal Received 14.9M Votes For and 27.3M Against

6 jan 2026, 22:03 UTC

Acquisities, Fusies, Overnames

Staar Surgical, Which Earlier Reported Stockholder Rejection of Sale to Alcon, Reports Vote Totals

6 jan 2026, 21:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

6 jan 2026, 21:15 UTC

Marktinformatie

Global Commodities Roundup: Market Talk

6 jan 2026, 21:12 UTC

Marktinformatie

Market Talk Roundup: Latest on U.S. Politics

6 jan 2026, 21:12 UTC

Marktinformatie

Commodity Demand Helps Canada Reduce Reliance on Trade With U.S. -- Market Talk

6 jan 2026, 20:59 UTC

Belangrijke Marktbewegers

Acquisities, Fusies, Overnames

Ventyx Biosciences Gains on Report of Possible $1B Eli Lilly Deal

6 jan 2026, 20:40 UTC

Acquisities, Fusies, Overnames

Acquisition of Ventyx Would Bring Lilly Into Emerging Category of Pills for Inflammation-Related Conditions -- WSJ

6 jan 2026, 20:40 UTC

Acquisities, Fusies, Overnames

Eli Lilly Nears Deal for Biotech Ventyx -- WSJ

6 jan 2026, 20:40 UTC

Acquisities, Fusies, Overnames

Deal Could Be Announced Imminently, Sources Say -- WSJ

6 jan 2026, 20:40 UTC

Acquisities, Fusies, Overnames

Eli Lilly in Advanced Talks to Buy Ventyx Biosciences For Over $1B, Sources Say -- WSJ

6 jan 2026, 20:01 UTC

Marktinformatie

Oil Futures Give Back Post-Venezuela Incursion Gains -- Market Talk

6 jan 2026, 19:52 UTC

Marktinformatie

U.S. Natural Gas Falls Awaiting Colder Weather -- Market Talk

6 jan 2026, 19:46 UTC

Acquisities, Fusies, Overnames

Under Armour Stock Rises After the 'Warren Buffet of Canada' Boosts Its Stake -- Barrons.com

6 jan 2026, 19:08 UTC

Acquisities, Fusies, Overnames

OneStream to Go Private Through $6.4B Hg Acquisition

6 jan 2026, 18:28 UTC

Acquisities, Fusies, Overnames

These Stocks Are Moving the Most Today: Sandisk, Nvidia, AMD, Palantir, OneStream, SoFi, Microchip, and More -- Barrons.com

6 jan 2026, 17:20 UTC

Marktinformatie

Winsten

Financial Services Roundup: Market Talk

6 jan 2026, 17:20 UTC

Marktinformatie

Acquisities, Fusies, Overnames

Health Care Roundup: Market Talk

6 jan 2026, 15:57 UTC

Marktinformatie

Crude Futures Ease Back From Early Gains -- Market Talk

6 jan 2026, 15:34 UTC

Marktinformatie

Winsten

Bank of Montreal Expects to Exit 2027 With ROE Hitting 15% Target -- Market Talk

6 jan 2026, 15:27 UTC

Marktinformatie

German Inflation Won't Fall Much Further in 2026 -- Market Talk

Peer Vergelijking

Prijswijziging

Pulse Biosciences Inc Prognose

Koersdoel

By TipRanks

49.97% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 22 USD 49.97%

Hoogste 22 USD

Laagste 22 USD

Gebaseerd op 1 Wall Street-analisten die 12-maands prijsdoelen bieden voor Pulse Biosciences Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

1 ratings

Buy

Hold

Sell

Gebaseerd op 1 analisten die aandelenratings hebben gegeven aan Pulse Biosciences Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

16.59 / 17.17Steun & Weerstand

Recent bearish events outweigh bullish events.

Sentiment

By Acuity

164 / 373 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.